SCHEMBL30544026

SCHEMBL30544026

NCCCn1ccc(=O)c2ccc(-c3ccccc3Oc3ccc(C(F)(F)F)cc3)cc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 1/20 0.39
▸ SCN9A Q15858 4/20 0.38
▸ SCN5A Q14524 1/20 0.36
▸ CAMK2D Q13557 2/20 0.35
▸ BRD4 O60885 2/20 0.34
▸ ERBB2 P04626 1/20 0.34
▸ FEN1 P39748 5/20 0.33
▸ SCN8A Q9UQD0 1/20 0.33
▸ SCN10A Q9Y5Y9 1/20 0.33
▸ ABL1 P00519 1/20 0.33
▸ EGFR P00533 1/20 0.33
▸ PDGFRB P09619 1/20 0.33
▸ BCR P11274 1/20 0.33
▸ SRC P12931 1/20 0.33
▸ PDGFRA P16234 1/20 0.33
▸ PRKCA P17252 1/20 0.33
▸ PRKACA P17612 1/20 0.33
▸ PRKACG P22612 1/20 0.33
▸ PRKACB P22694 1/20 0.33
▸ PRKCD Q05655 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25428113 1.00 TRPV1 (0.39) TRPV1SCN9ASCN5ACAMK2DBRD4
SCHEMBL25952320 0.91 SCN9A (0.44) TRPV1SCN9ASCN5ABRD4ERBB2
SCHEMBL30544057 0.91 SCN9A (0.44) TRPV1SCN9ASCN5ABRD4ERBB2
SCHEMBL25429484 0.89 SCN8A (0.43) TRPV1SCN9ASCN5ABRD4ERBB2
SCHEMBL30544045 0.87 ICMT (0.39) TRPV1SCN9ASCN5AFEN1SCN8A
SCHEMBL25429756 0.87 ICMT (0.39) TRPV1SCN9ASCN5AFEN1SCN8A
SCHEMBL25429273 0.86 NOD2 (0.37) TRPV1SCN9ASCN5ASCN8ASCN10A
SCHEMBL25429629 0.84 TRPV1 (0.46) TRPV1SCN9ASCN5ABRD4
SCHEMBL30544106 0.83 PDPK1 (0.40) TRPV1CAMK2D
SCHEMBL25956089 0.83 PDPK1 (0.40) TRPV1CAMK2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023146511-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
Send feedback